Healthcare -
Biotechnology - NASDAQ - US
$ 2.68
0 %
$ 77.7 M
Market Cap
-0.045042016806722686
P/E
AVTE - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AVTE - Aerovate Therapeutics, Inc.
25.4 M
LAST VALUE
701.31%
2 YEAR CAGR
59.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR